<p>随着全球市场的反弹，澳大利亚证券交易所（ASX）在九月份通常的熊市趋势中表现出韧性，受到近期降息和主要金融机构经济信号的提振。在这种背景下，尽管 “便士股票” 这一术语有些过时，但仍然为希望探索具有增长潜力的小型或新兴公司的投资者提供了有趣的机会。虽然这些股票通常伴随风险，但那些财务健康状况良好的公司可以提供显著的上行潜力，使其在当今市场环境中值得关注。</p>
<h3>澳大利亚十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Alfabs Australia (ASX:AAL)</td>
<td>A$0.49</td>
<td>A$140.43M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.18</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Dusk Group (ASX:DSK)</td>
<td>A$0.815</td>
<td>A$50.75M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>IVE Group (ASX:IGL)</td>
<td>A$2.67</td>
<td>A$412.55M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>MotorCycle Holdings (ASX:MTO)</td>
<td>A$3.50</td>
<td>A$258.32M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Pureprofile (ASX:PPL)</td>
<td>A$0.043</td>
<td>A$50.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Veris (ASX:VRS)</td>
<td>A$0.075</td>
<td>A$38.83M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>West African Resources (ASX:WAF)</td>
<td>A$3.04</td>
<td>A$3.47B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Praemium (ASX:PPS)</td>
<td>A$0.76</td>
<td>A$363.06M</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Service Stream (ASX:SSM)</td>
<td>A$2.30</td>
<td>A$1.41B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们 ASX 便士股票筛选器中的 427 只股票的完整列表。</p>
<p>让我们探索筛选结果中的几个突出选项。</p>
<h2>Archer Materials (ASX:AXE)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Archer Materials Limited 是一家专注于开发和商业化半导体设备和传感器的科技公司，涉及量子计算、医疗诊断、TMR 传感器和实验室芯片技术，市值为 A$75.18 百万。</p>
<p><strong>运营：</strong> 该公司从其材料技术研发部门产生的收入为 A$2.06 百万。</p>
<p><strong>市值：</strong> A$75.18M</p>
<p>Archer Materials Limited 是一家半导体领域的科技公司，预计在 2025 年 6 月结束的财年报告收入为 A$2.8 百万。尽管处于亏损状态，净亏损为 A$6.97 百万，但通过无债务状态和基于当前自由现金流超过三年的充足现金流保持财务稳定。公司的短期资产显著超过其负债，表明流动性管理良好。然而，过去五年中，收益年均下降 10.1%，近期股东稀释情况较少，周波动性稳定在 10%。</p>
<ul>
<li>在我们的财务健康报告中更详细地了解 Archer Materials 的潜力。</li>
<li>探索历史数据，以跟踪 Archer Materials 随时间的表现，在我们的过去结果报告中。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9020cb3c-7ddc-42da-92a4-c32aac24964a/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9020cb3c-7ddc-42da-92a4-c32aac24964a/chart/financial-position-analysis"/></p>
<p>ASX:AXE 财务状况分析截至 2025 年 9 月</p>
<h2>Peet (ASX:PPC)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Peet Limited 在澳大利亚收购、开发和销售住宅用地，市值为 A$833.32 百万。</p>
<p><strong>运营：</strong> 公司的收入来自资金管理（A$56.39 百万）、联合安排（A$51.88 百万）和公司自有项目（A$313.24 百万）。</p>
<p><strong>市值：</strong> A$833.32M</p>
<p>Peet Limited 在过去一年中表现出强劲的财务增长，收益增长了 60%，超过了其五年平均水平和行业基准。公司的净利润率有所改善，得益于严格的战略方法和澳大利亚住宅房地产市场的有利条件。尽管债务水平较高，Peet 的利息支付由 EBIT 良好覆盖，表明财务义务可控。该公司目前正在进行由高盛主导的战略审查，以优化其资产基础并进一步利用市场机会。近期的股息增加反映了 Peet 在稳定的周波动性中回馈股东的承诺。</p>
<ul>
<li>点击探索我们在 Peet 财务健康报告中的详细发现。</li>
<li>查看我们的历史业绩报告，以获取 Peet 的业绩记录的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/993b423f-f3f9-4d37-9bcf-21b98c0b895b/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/993b423f-f3f9-4d37-9bcf-21b98c0b895b/chart/financial-position-analysis"/></p>
<p>ASX:PPC 财务状况分析截至 2025 年 9 月</p>
<h2>XRF Scientific (ASX:XRF)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> XRF Scientific Limited 在澳大利亚、加拿大和欧洲制造和销售贵金属产品、专业化学品和仪器，服务于科学、分析、建筑材料和矿业行业，市值为 A$306.01 百万。</p>
<p><strong>运营：</strong> 公司的收入来自三个主要部门：消耗品（A$19.26 百万）、贵金属（A$21.51 百万）和资本设备（A$22.56 百万）。</p>
<p><strong>市值：</strong> A$306.01M</p>
<p>XRF Scientific Limited 在过去五年中表现出稳定的财务表现，收益年均增长 20.3%，尽管最近的增长 16.9% 未能超过行业平均水平。该公司保持强劲的资产负债表，短期资产显著超过长期和短期负债，且债务由经营现金流良好覆盖。尽管近期内部人士大量抛售，XRF 的管理层和董事会经验丰富，任期平均超过 12 年。最近被纳入 S&amp;P 全球 BMI 指数和股息增加表明市场情绪积极，净利润率较去年有所改善。</p>
<ul>
<li>在这里深入了解 XRF Scientific 的详细资产负债表健康报告。</li>
<li>在这里了解 XRF Scientific 的未来增长轨迹。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9b63580b-4082-4ba3-bd48-ba43082e3621/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9b63580b-4082-4ba3-bd48-ba43082e3621/chart/debt-equity-history-analysis"/></p>
<p>截至 2025 年 9 月 ASX:XRF 的债务与股本历史及分析</p>
<h2>利用机会</h2>
<ul>
<li>点击这里解锁我们全面的 427 只 ASX 便士股票列表。</li>
<li>寻找新视角？超越巨头：这 24 只早期 AI 股票可能为您的退休提供资金。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>

<p>ASX 在全球市场反弹中展现出韧性，低价股提供了引人注目的投资机会。市值低于 9 亿澳元的显著股票包括 Alfabs Australia（1.4043 亿澳元）、EZZ Life Science Holdings（1.0284 亿澳元）和 Dusk Group（5075 万澳元）。Archer Materials（7518 万澳元）专注于半导体技术，但仍处于无收入阶段。Peet Limited（8.3332 亿澳元）实现了 60% 的盈利增长，而 XRF Scientific（3.0601 亿澳元）则保持强劲的财务健康，持续增长。鼓励投资者在当前市场环境中探索这些选项</p>

<p>As global markets rally, the ASX has shown resilience against September's usual bearish trends, buoyed by recent rate cuts and economic signals from major financial institutions. In this context, penny stocks—though a somewhat outdated term—continue to offer intriguing opportunities for investors looking to explore smaller or newer companies with growth potential. While these stocks often come with risks, those backed by strong financial health can provide significant upside potential, making them worth watching in today's market landscape.</p>
<div class="lb-trans"><p>随着全球市场的反弹，澳大利亚证券交易所（ASX）在九月份通常的熊市趋势中表现出韧性，受到近期降息和主要金融机构经济信号的提振。在这种背景下，尽管 “便士股票” 这一术语有些过时，但仍然为希望探索具有增长潜力的小型或新兴公司的投资者提供了有趣的机会。虽然这些股票通常伴随风险，但那些财务健康状况良好的公司可以提供显著的上行潜力，使其在当今市场环境中值得关注。</p>
</div><h3>Top 10 Penny Stocks In Australia</h3>
<div class="lb-trans"><h3>澳大利亚十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Alfabs Australia (ASX:AAL)</td>
<td>A$0.49</td>
<td>A$140.43M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.18</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Dusk Group (ASX:DSK)</td>
<td>A$0.815</td>
<td>A$50.75M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>IVE Group (ASX:IGL)</td>
<td>A$2.67</td>
<td>A$412.55M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>MotorCycle Holdings (ASX:MTO)</td>
<td>A$3.50</td>
<td>A$258.32M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Pureprofile (ASX:PPL)</td>
<td>A$0.043</td>
<td>A$50.3M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Veris (ASX:VRS)</td>
<td>A$0.075</td>
<td>A$38.83M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>West African Resources (ASX:WAF)</td>
<td>A$3.04</td>
<td>A$3.47B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Praemium (ASX:PPS)</td>
<td>A$0.76</td>
<td>A$363.06M</td>
<td>✅ 5 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Service Stream (ASX:SSM)</td>
<td>A$2.30</td>
<td>A$1.41B</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Alfabs Australia (ASX:AAL)</td>
<td>A$0.49</td>
<td>A$140.43M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.18</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Dusk Group (ASX:DSK)</td>
<td>A$0.815</td>
<td>A$50.75M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>IVE Group (ASX:IGL)</td>
<td>A$2.67</td>
<td>A$412.55M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>MotorCycle Holdings (ASX:MTO)</td>
<td>A$3.50</td>
<td>A$258.32M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Pureprofile (ASX:PPL)</td>
<td>A$0.043</td>
<td>A$50.3M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Veris (ASX:VRS)</td>
<td>A$0.075</td>
<td>A$38.83M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>West African Resources (ASX:WAF)</td>
<td>A$3.04</td>
<td>A$3.47B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Praemium (ASX:PPS)</td>
<td>A$0.76</td>
<td>A$363.06M</td>
<td>✅ 5 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Service Stream (ASX:SSM)</td>
<td>A$2.30</td>
<td>A$1.41B</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 427 stocks from our ASX Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们 ASX 便士股票筛选器中的 427 只股票的完整列表。</p>
</div><p>Let's explore several standout options from the results in the screener.</p>
<div class="lb-trans"><p>让我们探索筛选结果中的几个突出选项。</p>
</div><h2>Archer Materials (ASX:AXE)</h2>
<div class="lb-trans"><h2>Archer Materials (ASX:AXE)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Archer Materials Limited is a technology company focused on developing and commercializing semiconductor devices and sensors for quantum computing, medical diagnostics, TMR sensors, and lab-on-a-chip technologies in Australia, with a market cap of A$75.18 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Archer Materials Limited 是一家专注于开发和商业化半导体设备和传感器的科技公司，涉及量子计算、医疗诊断、TMR 传感器和实验室芯片技术，市值为 A$75.18 百万。</p>
</div><p><strong>Operations:</strong> The company generates revenue of A$2.06 million from its Materials Technology Research and Development segment.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司从其材料技术研发部门产生的收入为 A$2.06 百万。</p>
</div><p><strong>Market Cap:</strong> A$75.18M</p>
<div class="lb-trans"><p><strong>市值：</strong> A$75.18M</p>
</div><p>Archer Materials Limited, a technology company in the semiconductor sector, remains pre-revenue with A$2.8 million reported for the year ending June 2025. Despite being unprofitable, with a net loss of A$6.97 million, it maintains financial stability through its debt-free status and sufficient cash runway exceeding three years based on current free cash flow. The company's short-term assets significantly surpass its liabilities, indicating sound liquidity management. However, earnings have declined by 10.1% annually over five years and shareholder dilution has been minimal recently amidst stable weekly volatility of 10%.</p>
<div class="lb-trans"><p>Archer Materials Limited 是一家半导体领域的科技公司，预计在 2025 年 6 月结束的财年报告收入为 A$2.8 百万。尽管处于亏损状态，净亏损为 A$6.97 百万，但通过无债务状态和基于当前自由现金流超过三年的充足现金流保持财务稳定。公司的短期资产显著超过其负债，表明流动性管理良好。然而，过去五年中，收益年均下降 10.1%，近期股东稀释情况较少，周波动性稳定在 10%。</p>
</div><ul>
<li>Take a closer look at Archer Materials' potential here in our financial health report.</li>
<li>Explore historical data to track Archer Materials' performance over time in our past results report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的财务健康报告中更详细地了解 Archer Materials 的潜力。</li>
<li>探索历史数据，以跟踪 Archer Materials 随时间的表现，在我们的过去结果报告中。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9020cb3c-7ddc-42da-92a4-c32aac24964a/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/9020cb3c-7ddc-42da-92a4-c32aac24964a/chart/financial-position-analysis"/></p>
<p>ASX:AXE Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>ASX:AXE 财务状况分析截至 2025 年 9 月</p>
</div><h2>Peet (ASX:PPC)</h2>
<div class="lb-trans"><h2>Peet (ASX:PPC)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Peet Limited acquires, develops, and markets residential land in Australia with a market cap of A$833.32 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Peet Limited 在澳大利亚收购、开发和销售住宅用地，市值为 A$833.32 百万。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from Funds Management (A$56.39 million), Joint Arrangements (A$51.88 million), and Company Owned Projects (A$313.24 million).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自资金管理（A$56.39 百万）、联合安排（A$51.88 百万）和公司自有项目（A$313.24 百万）。</p>
</div><p><strong>Market Cap:</strong> A$833.32M</p>
<div class="lb-trans"><p><strong>市值：</strong> A$833.32M</p>
</div><p>Peet Limited has demonstrated robust financial growth with its earnings increasing by 60% over the past year, surpassing both its five-year average and industry benchmarks. The company's net profit margins have improved, supported by a disciplined strategic approach and favorable market conditions in the Australian residential property sector. Despite high debt levels, Peet's interest payments are well-covered by EBIT, indicating manageable financial obligations. The company is currently undergoing a strategic review led by Goldman Sachs to optimize its asset base and leverage market opportunities further. Recent dividend increases reflect Peet's commitment to returning value to shareholders amidst stable weekly volatility.</p>
<div class="lb-trans"><p>Peet Limited 在过去一年中表现出强劲的财务增长，收益增长了 60%，超过了其五年平均水平和行业基准。公司的净利润率有所改善，得益于严格的战略方法和澳大利亚住宅房地产市场的有利条件。尽管债务水平较高，Peet 的利息支付由 EBIT 良好覆盖，表明财务义务可控。该公司目前正在进行由高盛主导的战略审查，以优化其资产基础并进一步利用市场机会。近期的股息增加反映了 Peet 在稳定的周波动性中回馈股东的承诺。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Peet's financial health report.</li>
<li>Review our historical performance report to gain insights into Peet's track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们在 Peet 财务健康报告中的详细发现。</li>
<li>查看我们的历史业绩报告，以获取 Peet 的业绩记录的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/993b423f-f3f9-4d37-9bcf-21b98c0b895b/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/993b423f-f3f9-4d37-9bcf-21b98c0b895b/chart/financial-position-analysis"/></p>
<p>ASX:PPC Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>ASX:PPC 财务状况分析截至 2025 年 9 月</p>
</div><h2>XRF Scientific (ASX:XRF)</h2>
<div class="lb-trans"><h2>XRF Scientific (ASX:XRF)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries across Australia, Canada, and Europe with a market cap of A$306.01 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> XRF Scientific Limited 在澳大利亚、加拿大和欧洲制造和销售贵金属产品、专业化学品和仪器，服务于科学、分析、建筑材料和矿业行业，市值为 A$306.01 百万。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from three main segments: Consumables (A$19.26 million), Precious Metals (A$21.51 million), and Capital Equipment (A$22.56 million).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自三个主要部门：消耗品（A$19.26 百万）、贵金属（A$21.51 百万）和资本设备（A$22.56 百万）。</p>
</div><p><strong>Market Cap:</strong> A$306.01M</p>
<div class="lb-trans"><p><strong>市值：</strong> A$306.01M</p>
</div><p>XRF Scientific Limited has shown consistent financial performance with earnings growing at 20.3% annually over the past five years, though recent growth of 16.9% did not outperform the industry average. The company maintains a strong balance sheet, with short-term assets significantly exceeding both long and short-term liabilities, and debt well-covered by operating cash flow. Despite significant insider selling recently, XRF's management and board are experienced with lengthy tenures averaging over 12 years. Recent inclusion in the S&amp;P Global BMI Index and dividend increases indicate positive market sentiment as net profit margins have improved from last year.</p>
<div class="lb-trans"><p>XRF Scientific Limited 在过去五年中表现出稳定的财务表现，收益年均增长 20.3%，尽管最近的增长 16.9% 未能超过行业平均水平。该公司保持强劲的资产负债表，短期资产显著超过长期和短期负债，且债务由经营现金流良好覆盖。尽管近期内部人士大量抛售，XRF 的管理层和董事会经验丰富，任期平均超过 12 年。最近被纳入 S&amp;P 全球 BMI 指数和股息增加表明市场情绪积极，净利润率较去年有所改善。</p>
</div><ul>
<li>Dive into the specifics of XRF Scientific here with our thorough balance sheet health report.</li>
<li>Learn about XRF Scientific's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 XRF Scientific 的详细资产负债表健康报告。</li>
<li>在这里了解 XRF Scientific 的未来增长轨迹。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/9b63580b-4082-4ba3-bd48-ba43082e3621/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/9b63580b-4082-4ba3-bd48-ba43082e3621/chart/debt-equity-history-analysis"/></p>
<p>ASX:XRF Debt to Equity History and Analysis as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月 ASX:XRF 的债务与股本历史及分析</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Unlock our comprehensive list of 427 ASX Penny Stocks by clicking here.</li>
<li>Searching for a Fresh Perspective? Outshine the giants: these 24 early-stage AI stocks could fund your retirement.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里解锁我们全面的 427 只 ASX 便士股票列表。</li>
<li>寻找新视角？超越巨头：这 24 只早期 AI 股票可能为您的退休提供资金。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>
</div>

三只市值低于 9 亿澳元的 ASX 便士股票值得关注